Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

Berlín, Alemania--(BUSINESS WIRE)--TACTICAAI, una empresa de inteligencia para la toma de decisiones operativas, ha anunciado hoy una colaboración con NVIDIA para avanzar y ampliar la implementación de capacidades de IA agentiva. Las empresas colaborarán para integrar y optimizar los modelos NVIDIA Nemotron en la plataforma de inteligencia múltiple de TACTICAAI. Esto tiene como objetivo ampliar estas capacidades y respaldar su implementación con clientes clave a escala internacional. La colabor...

LOS ANGELES & ROAD TOWN, British Virgin Islands--(BUSINESS WIRE)--A familiar voice pleading for help can make a fabricated emergency feel real. The FBI’s 2025 Internet Crime Report records more than $5 million in reported losses to voice-cloning distress scams, describing criminals’ use of voice cloning to mimic loved ones in emergencies. The figure covers several family-emergency scenarios, not virtual kidnapping alone. Personal details exposed in data breaches, sometimes without the person’s...

BERLIN--(BUSINESS WIRE)--TACTICA AI and NVIDIA Collaborate to Scale Agentic AI Capabilities with NVIDIA Nemotron...

Berlino, Germania--(BUSINESS WIRE)--TACTICAAI, società specializzata in decision intelligence operativa, ha annunciato oggi una collaborazione con NVIDIA per far progredire e potenziare l'implementazione delle funzionalità di IA agentica. Le due società coopereranno per integrare e ottimizzare i modelli NVIDIA Nemotron all'interno della piattaforma multi-intelligenza di TACTICAAI, ponendo particolare attenzione all'ampliamento di tali capacità e al supporto dell'implementazione presso i princip...

Berlin, Allemagne--(BUSINESS WIRE)--TACTICAAI, entreprise spécialisée dans les technologies de renseignement décisionnel opérationnel, a annoncé aujourd'hui une collaboration avec NVIDIA pour faire progresser les capacités de l’IA agentique et accélérer leur déploiement à grande échelle. Dans le cadre de cette initiative, les deux entreprises collaboreront pour intégrer et optimiser les modèles NVIDIA Nemotron au sein de la plateforme multi-intelligence de TACTICAAI. Cette initiative permettra...

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its third quarter 2026 financial results on Thursday, November 5, 2026, before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. The live webcast of this event can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com.To ensure a...

TORONTO--(BUSINESS WIRE)--Securian Canada, a leading provider of inclusive and accessible insurance solutions, announced a new strategic association with Empathy, a technology company transforming how the world plans for and deals with life’s most difficult moments. Securian Canada’s new research reveals that after experiencing the death of an immediate family member, more than half (54 per cent) of respondents took on practical and administrative responsibilities. Among those, 42 per cent said...

SAN FRANCISCO--(BUSINESS WIRE)--Expensify, Inc. (Nasdaq: EXFY), the easiest way to manage expenses, corporate cards, and travel, today announced that the company’s Q3 2026 financial results will be released after market close on Thursday, November 5th, 2026.Expensify will host a call to discuss its Q3 2026 results on Thursday, November 5th, 2026 at 2pm PT / 5pm ET. The link to the call will be available that day on the company’s Investor Relations website at investors.expensify.com. Prior to the...

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that ivonescimab data will be featured in numerous presentations at the European Society for Medical Oncology 2026 Congress (ESMO 2026), taking place October 23-27, 2026, in Madrid, Spain. Across 10 presentations at ESMO 2026, ivonescimab data will span a broad range of tumor types, led by positive overall survival findings from Akeso Inc.’s Phase III HARMONi-GI1 study of ivonescimab plus chemotherapy compared to du...